No profit upgrade today
Suppose we have to wait longer for that
As $27m for F22 isn’t much more than $25.5m in F21
Printable View
No profit upgrade today
Suppose we have to wait longer for that
As $27m for F22 isn’t much more than $25.5m in F21
I missed a good part of the conference call . Was there any mention of any improvement in the Daigou Australian/Nz market? Overall nothing new since the Q1 update. I guess a little early after only 3 months for a profit upgrade.
Chair Brett Hewlett was asked about the company’s share price, which is currently $3.75, having remained largely static over the year despite the positive full-year earnings announcement.
“The one thing that keeps me awake at night is that our share price poorly reflects the true capability of this organisation,” Hewlett said.
“We just have to just focus on business fundamentals and be ... focused on improving earnings growth as well as we can, while also investing in our brand story – there’s value to be had from CVT.”
Another great article. Well worth a read.
https://www.newsroom.co.nz/multi-million-dollar-manuka-industry-faces-mandatory-tests?amp=1
According to asx update demand for Bubs infant formula has surged in the Daigou channel up to 6.5 times on prior year. And up 265 percent quarter on quarter. This has got to be good news for CVT as Australia re opens. I also hear that the Manuka season looking good.
I’m thinking of topping up. Be interested in your thoughts?